Plasmablastic lymphoma of the elderly: A clinicopathological comparison with age-related Epstein-Barr virus-associated B cell lymphoproliferative disorder

Histopathology

Volumn 61, Issue 6, 2012, Pages 1183-1197

  Liu, Fang ^a   Asano, Naoko ^a   Tatematsu, Akiko ^a   Oyama, Takashi ^b   Kitamura, Kunio ^c   Suzuki, Kotaro ^d   Yamamoto, Kazuhito ^e   Sakamoto, Natsumi ^f   Taniwaki, Masafumi ^f   Kinoshita, Tomohiro ^e   Nakamura, Shigeo ^a  

^a NAGOYA UNIVERSITY HOSPITAL   (Japan)

^b NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^c Ichinomiya Municipal Hospital   (Japan)

^d TOYOHASHI MUNICIPAL HOSPITAL   (Japan)

^e AICHI CANCER CENTER HOSPITAL   (Japan)

^f KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Elderly; Epstein Barr virus; Human immunodeficiency virus (HIV) negative; Lymphoid malignancy; Plasmablastic lymphoma

Indexed keywords

BORTEZOMIB; CARBOPLATIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; IMMUNOGLOBULIN HEAVY CHAIN; PREDNISONE; VINCRISTINE;

ADULT; AGE; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; DISEASE ASSOCIATION; DISEASE COURSE; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FEMALE; GENE TRANSLOCATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ONCOGENE MYC; OVERALL SURVIVAL; PLASMABLASTIC LYMPHOMA; PRIORITY JOURNAL;

AGE FACTORS; AGED; AGED, 80 AND OVER; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; LYMPHOMA, B-CELL; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-MYC; TRANSLOCATION, GENETIC;

HUMAN HERPESVIRUS 4; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84870390028     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2012.04339.x     Document Type: Article

References (40)

1. Delecluse HJ, Anagnostopoulos I, Dallenbach F et al. Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood 1997; 89; 1413-1420.
2. Castillo JJ, Winer ES, Stachurski D et al. Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma. Leuk. Lymphoma 2010; 51; 2047-2053.
3. Colomo L, Loong F, Rives S et al. Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am. J. Surg. Pathol. 2004; 28; 736-747.
4. Qing X, Sun N, Chang E, French S, Ji P, Yue C. Plasmablastic lymphoma may occur as a high-grade transformation from plasmacytoma. Exp. Mol. Pathol. 2011; 90; 85-90.
5. Asano N, Yamamoto K, Tamaru J et al. Age-related Epstein-Barr virus (EBV)-associated B-cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly patients. Blood 2009; 113; 2629-2636.
6. Oyama T, Ichimura K, Suzuki R et al. Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients. Am. J. Surg. Pathol. 2003; 27; 16-26.
7. Oyama T, Yamamoto K, Asano N et al. Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients. Clin. Cancer Res. 2007; 13; 5124-5132.
8. Dojcinov SD, Venkataraman G, Pittaluga S et al. Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma. Blood 2011; 117; 4726-4735.
9. Dojcinov SD, Venkataraman G, Raffeld M, Pittaluga S, Jaffe ES. EBV positive mucocutaneous ulcer - a study of 26 cases associated with various sources of immunosuppression. Am. J. Surg. Pathol. 2010; 34; 405-417.
10. Kojima M, Kashimura M, Itoh H et al. Epstein-Barr virus-related reactive lymphoproliferative disorders in middle-aged or elderly patients presenting with atypical features. A clinicopathological study of six cases. Pathol. Res. Pract. 2007; 203; 587-591.
11. Shimoyama Y, Asano N, Kojima M et al. Age-related EBV-associated B-cell lymphoproliferative disorders: diagnostic approach to a newly recognized clinicopathological entity. Pathol. Int. 2009; 59; 835-843.
12. Asano N, Oshiro A, Matsuo K et al. Prognostic significance of T-cell or cytotoxic molecules phenotype in classical Hodgkin's lymphoma: a clinicopathologic study. J. Clin. Oncol. 2006; 24; 4626-4633.
13. Nguyen DD, Loo BW, Tillman G et al. Plasmablastic lymphoma presenting in a human immunodeficiency virus-negative patient: a case report. Ann. Hematol. 2003; 82; 521-525.
14. Lin F, Zhang K, Quiery AT, Prichard J, Schuerch C. Plasmablastic lymphoma of the cervical lymph nodes in a human immunodeficiency virus-negative patient: a case report and review of the literature. Arch. Pathol. Lab. Med. 2004; 128; 581-584.
15. Teruya-Feldstein J, Chiao E, Filippa DA et al. CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients. Ann. Oncol. 2004; 15; 1673-1679.
16. Tzankov A, Brunhuber T, Gschwendtner A, Brunner A. Incidental oral plasmablastic lymphoma with aberrant expression of CD4 in an elderly HIV-negative patient: how a gingival polyp can cause confusion. Histopathology 2005; 46; 348-350.
17. Scheper MA, Nikitakis NG, Fernandes R, Gocke CD, Ord RA, Sauk JJ. Oral plasmablastic lymphoma in an HIV-negative patient: a case report and review of the literature. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2005; 100; 198-206.
18. Kim JE, Kim YA, Kim WY et al. Human immunodeficiency virus-negative plasmablastic lymphoma in Korea. Leuk. Lymphoma 2009; 50; 582-587.
19. Takahashi Y, Saiga I, Fukushima J et al. Plasmablastic lymphoma of the retroperitoneum in an HIV-negative patient. Pathol. Int. 2009; 59; 868-873.
20. Suzuki Y, Yoshida T, Nakamura N et al. CD3- and CD4-positive plasmablastic lymphoma: a literature review of Japanese plasmablastic lymphoma cases. Intern. Med. 2010; 49; 1801-1805.
21. Brahmania M, Sylwesterowic T, Leitch H. Plasmablastic lymphoma in the anorectal junction presenting in an immunocompetent man: a case report. J. Med. Case Rep. 2011; 5; 168.
22. Van RA, Mason D, Jones M et al. Translocation detection in lymphoma diagnosis by split-signal FISH: a standardised approach. J. Hematop. 2008; 1; 119-126.
23. Ventura RA, Martin-Subero JI, Jones M et al. FISH analysis for the detection of lymphoma-associtated chromosomal abnormalities in routine parafin-embedded tissue. J. Mol. Diagn. 2006; 8; 141-151.
24. Hans CP, Weisenburger DD, Greiner TC et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004; 103; 275-282.
25. Hansra D, Montague N, Stefanovic A et al. Oral and extraoral plasmablastic lymphoma: similarities and differences in clinicopathologic characteristics. Am. J. Clin. Pathol. 2010; 134; 710-719.
26. Momose H, Jaffe ES, Shin SS, Chen YY, Weiss LM. Chronic lymphocytic leukemia/small lymphocytic lymphoma with Reed-Sternberg-like cells and possible transformation to Hodgkin's disease. Mediation by Epstein-Barr virus. Am. J. Surg. Pathol. 1992; 16; 859-867.
27. Khan G, Norton AJ, Slavin G. Epstein-Barr virus in Reed-Sternberg-like cells in non-Hodgkin's lymphomas. J. Pathol. 1993; 169; 9-14.
28. Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood 2011; 117; 5019-5032.
29. Liu JJ, Zhang L, Ayala E et al. Human immunodeficiency virus (HIV)-negative plasmablastic lymphoma: a single institutional experience and literature review. Leuk. Res. 2011; 35; 1571-1577.
30. Castillo JJ, Winer ES, Stachurski D et al. HIV-negative plasmablastic lymphoma: not in the mouth. Clin. Lymphoma Myeloma Leuk. 2011; 11; 185-189.
31. Castillo JJ, Reagan JL. Plasmablastic lymphoma: a systematic review. Sci. World J. 2011; 11; 687-696.
32. Bogusz AM, Seegmiller AC, Garcia R, Shang P, Ashfaq R, Chen W. Plasmablastic lymphomas with MYC/IgH rearrangement: report of three cases and review of the literature. Am. J. Clin. Pathol. 2009; 132; 597-605.
33. Chapman-Fredricks J, Montague N, Ikpatt O. Extraoral plasmablastic lymphoma with intravascular component and MYC translocation. Ann. Diagn. Pathol. 2012; 16; 48-53.
34. Dawson MA, Schwarer AP, McLean C et al. AIDS-related plasmablastic lymphoma of the oral cavity associated with an IGH/MYC translocation - treatment with autologous stem-cell transplantation in a patient with severe haemophilia-A. Haematologica 2007; 92; e11-e12.
35. Taddesse-Heath L, Meloni-Ehrig A, Scheerle J, Kelly JC, Jaffe ES. Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features. Mod. Pathol. 2010; 23; 991-999.
36. Valera A, Balagué O, Colomo L et al. IG/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas. Am. J. Surg. Pathol. 2010; 34; 1686-1694.
37. Yotsumoto M, Ichikawa N, Ueno M, Higuchi Y, Asano N, Kobayashi H. CD20-negative CD138-positive leukemic large cell lymphoma with plasmablastic differentiation with an IgH/MYC translocation in an HIV-positive patient. Intern. Med. 2009; 48; 559-562.
38. Boxer LM, Dang CV. Translocations involving c-myc and c-myc function. Oncogene 2001; 20; 5595-5610.
39. Slack GW, Gascoyne RD. MYC and aggressive B-cell lymphomas. Adv. Anat. Pathol. 2011; 18; 219-228.
40. Castillo JJ, Pantanowitz L, Dezube BJ. HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases. Am. J. Hematol. 2008; 83; 804-809.